XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021 22,498,827        
Beginning balance at Dec. 31, 2021 $ 255,909        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Issuance of Series D convertible preferred stock, net of issuance costs (in shares) 12,443,676        
Issuance of Series D convertible preferred stock, net of issuance costs $ 159,349        
Ending balance (in shares) at Sep. 30, 2022 34,942,503        
Ending balance at Sep. 30, 2022 $ 415,258        
Beginning balance (shares) at Dec. 31, 2021   3,138,956      
Beginning balance at Dec. 31, 2021 (54,574) $ 0 $ 771 $ (239) $ (55,106)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Deemed dividend upon down round of common stock 0   4,550   (4,550)
Issuance of common stock (in shares)   851,943      
Issuance of common stock 6,548 $ 1 6,547    
Repurchase of common shares (in shares)   (194,514)      
Repurchase of common shares (1,860)       (1,860)
Exercise of vested stock options (in shares)   44,115      
Exercise of vested stock options 85   85    
Vesting of early exercised stock options and founder shares (in shares)   555,174      
Vesting of early exercised stock options and founder shares 620   620    
Stock-based compensation 4,219   4,219    
Other noncash compensation 269   269    
Unrealized gain (loss) on investment securities (696)     (696)  
Net loss (53,898)       (53,898)
Ending balance (shares) at Sep. 30, 2022   4,395,674      
Ending balance at Sep. 30, 2022 $ (99,287) $ 1 17,061 (935) (115,414)
Beginning balance (in shares) at Dec. 31, 2021 22,498,827        
Beginning balance at Dec. 31, 2021 $ 255,909        
Ending balance (in shares) at Dec. 31, 2022 34,942,503        
Ending balance at Dec. 31, 2022 $ 415,258        
Beginning balance (shares) at Dec. 31, 2021   3,138,956      
Beginning balance at Dec. 31, 2021 (54,574) $ 0 771 (239) (55,106)
Ending balance (shares) at Dec. 31, 2022   4,532,751      
Ending balance at Dec. 31, 2022 $ (111,294) $ 1 19,374 (553) (130,116)
Beginning balance (in shares) at Jun. 30, 2022 22,498,827        
Beginning balance at Jun. 30, 2022 $ 255,909        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Issuance of Series D convertible preferred stock, net of issuance costs (in shares) 12,443,676        
Issuance of Series D convertible preferred stock, net of issuance costs $ 159,349        
Ending balance (in shares) at Sep. 30, 2022 34,942,503        
Ending balance at Sep. 30, 2022 $ 415,258        
Beginning balance (shares) at Jun. 30, 2022   3,401,685      
Beginning balance at Jun. 30, 2022 (87,154) $ 0 4,300 (1,037) (90,417)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Deemed dividend upon down round of common stock 0   4,550   (4,550)
Issuance of common stock (in shares)   851,943      
Issuance of common stock 6,548 $ 1 6,547    
Exercise of vested stock options (in shares)   5,153      
Exercise of vested stock options 10   10    
Vesting of early exercised stock options and founder shares (in shares)   136,893      
Vesting of early exercised stock options and founder shares 119   119    
Stock-based compensation 1,447   1,447    
Other noncash compensation 88   88    
Unrealized gain (loss) on investment securities 102     102  
Net loss (20,447)       (20,447)
Ending balance (shares) at Sep. 30, 2022   4,395,674      
Ending balance at Sep. 30, 2022 $ (99,287) $ 1 17,061 (935) (115,414)
Beginning balance (in shares) at Dec. 31, 2022 34,942,503        
Beginning balance at Dec. 31, 2022 $ 415,258        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Conversion of convertible preferred stock into common stock (in shares) (34,942,503)        
Conversion of convertible preferred stock into common stock $ (415,258)        
Ending balance (in shares) at Sep. 30, 2023 0        
Ending balance at Sep. 30, 2023 $ 0        
Beginning balance (shares) at Dec. 31, 2022   4,532,751      
Beginning balance at Dec. 31, 2022 (111,294) $ 1 19,374 (553) (130,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Deemed dividend upon down round of common stock 0   1,209   (1,209)
Conversion of convertible preferred stock into common stock (in shares)   35,616,773      
Conversion of convertible preferred stock into common stock 415,258 $ 3 415,255    
Issuance of common stock (in shares)   18,706,240      
Issuance of common stock $ 310,402 $ 2 310,400    
Exercise of vested stock options (in shares) 1,209,126 463,559      
Exercise of vested stock options $ 1,475   1,475    
Vesting of early exercised stock options and founder shares (in shares)   506,861      
Vesting of early exercised stock options and founder shares 722   722    
Stock-based compensation 7,195   7,195    
Other noncash compensation 199   199    
Unrealized gain (loss) on investment securities 167     167  
Net loss (48,802)       (48,802)
Ending balance (shares) at Sep. 30, 2023   59,826,184      
Ending balance at Sep. 30, 2023 $ 575,322 $ 6 755,829 (386) (180,127)
Beginning balance (in shares) at Jun. 30, 2023 34,942,503        
Beginning balance at Jun. 30, 2023 $ 415,258        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Conversion of convertible preferred stock into common stock (in shares) (34,942,503)        
Conversion of convertible preferred stock into common stock $ (415,258)        
Ending balance (in shares) at Sep. 30, 2023 0        
Ending balance at Sep. 30, 2023 $ 0        
Beginning balance (shares) at Jun. 30, 2023   5,242,552      
Beginning balance at Jun. 30, 2023 (135,489) $ 1 25,803 (566) (160,727)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Deemed dividend upon down round of common stock 0   1,209   (1,209)
Conversion of convertible preferred stock into common stock (in shares)   35,616,773      
Conversion of convertible preferred stock into common stock 415,258 $ 3 415,255    
Issuance of common stock (in shares)   18,706,240      
Issuance of common stock 310,402 $ 2 310,400    
Exercise of vested stock options (in shares)   60,844      
Exercise of vested stock options 197   197    
Vesting of early exercised stock options and founder shares (in shares)   199,775      
Vesting of early exercised stock options and founder shares 335   335    
Stock-based compensation 2,564   2,564    
Other noncash compensation 66   66    
Unrealized gain (loss) on investment securities 180     180  
Net loss (18,191)       (18,191)
Ending balance (shares) at Sep. 30, 2023   59,826,184      
Ending balance at Sep. 30, 2023 $ 575,322 $ 6 $ 755,829 $ (386) $ (180,127)